|
Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients |
|
|
|
Titel: |
Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients |
Auteur: |
Luis, Buzon-Martín Miguel, Montero-Baladía Pedro, Delgado-López David, Iglesias-Posadilla Itziar, Astigarraga Ana, Galacho-Harriero Enrique, Iglesias-Julián María, López-Veloso Noelia, De La Torre-Ferrera Julio César, Barraza-Bengoechea Marta, Ubeira- Iglesias Rodrigo, San Llorente- Sebastián María, Colazo-Burlato Andrés, Lorenzo-Martín Javier, Minguito de la Iglesia Juan Pablo, García-Muñoz Gerardo, Hermida-Fernández Carolina, Navarro-San Francisco Jorge, Boado-Lama María, Fernández-Regueras Fernando, Callejo-Torre Sergio, Ossa-Echeverri Lourdes, Fisac-Cuadrado María, Gero-Escapa Gregoria, Megías-Lobón Adolfo, Simón-Rodríguez José Antonio, Fernández-Ratero |
Verschenen in: |
Journal of translational autoimmunity |
Paginering: |
Jaargang 4 () nr. C pagina's p. |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
The Author(s) |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|